CCNE1 and ovarian serous adenocarcinoma: Another analysis by Dariush et al. identified two mechanisms associated with primary resistance in advanced serous ovarian cancer, involving amplifying 19q12, which contains CCNE1 related to TPX2 amplification and 20q11.22-q13.12 and mapping immediately adjacent to the steroid receptor coactivator NCOA3.